Cogent Biosciences, Inc. Common Stock (COGT) Stock Price

COGTStock

$36.80+198.93%52W

Market Cap$6.39B

P/E—

PEG Ratio—

Div yield—

Beta0.31

COGT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-16.77%

Price vs S&P 500 (4W)-13.97%

VGM Score38.33

Book Value / Share (Quarterly)$3.56

P/TBV (Annual)2.25x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-1.68

Price vs S&P 500 (YTD)-9.96%

Net Profit Margin (TTM)-264.08%

EPS (TTM)$-2.51

10-Day Avg Trading Volume1.81M

EPS Excl Extra (TTM)$-2.51

EPS (Annual)$-2.46

ROI (Annual)-99.89%

Net Profit Margin (5Y Avg)-407.35%

Cash / Share (Quarterly)$5.07

ROA (Last FY)-78.07%

EBITD / Share (TTM)$-2.60

ROE (5Y Avg)-59.00%

Operating Margin (TTM)-295.77%

Cash Flow / Share (Annual)$-1.65

P/B Ratio10.71x

P/B Ratio (Quarterly)10.28x

Net Income / Employee (Annual)$-992,200

EV / Revenue (TTM)280.19x

ROA (TTM)-55.77%

EPS Incl Extra (Annual)$-2.46

Current Ratio (Annual)14.23x

Quick Ratio (Quarterly)14.94x

3-Month Avg Trading Volume2.24M

52-Week Price Return198.93%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$3.52

P/S Ratio (Annual)826.83x

Asset Turnover (Annual)0.03x

52-Week High$43.73

Operating Margin (5Y Avg)-434.04%

EPS Excl Extra (Annual)$-2.46

CapEx CAGR (5Y)80.39%

Tangible BV CAGR (5Y)55.30%

26-Week Price Return-5.53%

Quick Ratio (Annual)14.08x

13-Week Price Return11.20%

Total Debt / Equity (Annual)0.35x

Current Ratio (Quarterly)15.14x

Enterprise Value$6.49B

Asset Turnover (TTM)0.36x

Book Value / Share Growth (5Y)-11.46%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-950.57%

Cash / Share (Annual)$5.60

3-Month Return Std Dev46.22%

Net Income / Employee (TTM)$-1,373,300

ROE (Last FY)-99.89%

EPS Basic Excl Extra (Annual)$-2.46

Receivables Turnover (TTM)7.87x

Total Debt / Equity (Quarterly)0.37x

EPS Incl Extra (TTM)$-2.51

Receivables Turnover (Annual)7.87x

ROI (TTM)-63.39%

P/S Ratio (TTM)280.97x

Pretax Margin (5Y Avg)-407.35%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$3.66

Price vs S&P 500 (52W)180.62%

Year-to-Date Return2.00%

5-Day Price Return-3.13%

EPS Normalized (Annual)$-2.46

ROA (5Y Avg)-49.41%

Net Profit Margin (Annual)-950.57%

Month-to-Date Return-6.94%

Cash Flow / Share (TTM)$-2.32

EBITD / Share (Annual)$-2.63

Operating Margin (Annual)-1044.47%

LT Debt / Equity (Annual)0.35x

ROI (5Y Avg)-59.00%

LT Debt / Equity (Quarterly)0.37x

EPS Basic Excl Extra (TTM)$-2.51

P/TBV (Quarterly)1.90x

P/B Ratio (Annual)8.49x

Pretax Margin (TTM)-264.08%

Book Value / Share (Annual)$3.95

Price vs S&P 500 (13W)8.41%

Beta0.31x

P/FCF (Annual)413.68x

Revenue / Share (TTM)$0.00

ROE (TTM)-83.29%

52-Week Low$11.60

vGradeF

mGradeB

vgmGradeD

COGT Earnings Surprise History

Q2 25-0.53est. -0.58

Q3 25-0.50est. -0.53

Q4 25-0.56est. -0.51

Q1 26-0.53est. -0.54

Q2 26-0.52est. -0.56

COGT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.26

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$67.01

About Cogent Biosciences, Inc. Common Stock

Cogent Biosciences develops precision therapies for genetically defined diseases. Its lead program, CGT9486, is a selective tyrosine kinase inhibitor targeting KIT mutations—specifically D816V mutations that drive Systemic Mastocytosis and exon 17 mutations found in advanced gastrointestinal stromal tumors (GIST). The company addresses significant unmet medical needs in these serious hematologic and oncologic conditions.